C M Tsoukas - JoVE Visualize

Showing results (11-20 of 25) with videos related to

Pageof 3

Sort By:

Clinical Pharmacology and Therapeutics|October 23, 1997

N-acetylation among HIV-positive patients and patients with AIDS: when is fast, fast and slow, slow?W M O'Neil, B M Gilfix, A DiGirolamo, et al.

British Journal of Clinical Pharmacology|December 14, 1999

Glucuronidation and sulphation of paracetamol in HIV-positive patients and patients with AIDSW M O'Neil, J C Pezzullo, A Di Girolamo, et al.

AIDS (London, England)|December 2, 1998

HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected personsN F Bernard, K Pederson, F Chung, et al.

Clinical Nephrology|January 25, 2006

Low urine pH is associated with reduced indinavir crystalluria in indinavir-treated HIV-infected individualsR F Gagnon, A I Alli, M D Edwardes, et al.

American Journal of Nephrology|January 9, 2001

The natural history of leukocyturia associated with indinavir treatment in HIV+ individualsR F Gagnon, S N Tecimer, A K Watters, et al.

Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006

Selection of molecular descriptors with artificial intelligence for the understanding of HIV-1 protease peptidomimetic inhibitors-activityS Sirois, C M Tsoukas, Kuo-Chen Chou, et al.

Archives of Surgery (Chicago, Ill. : 1960)|January 23, 1998

Effect of splenectomy on slowing human immunodeficiency virus disease progressionC M Tsoukas, N F Bernard, M Abrahamowicz, et al.

European Journal of Clinical Pharmacology|August 22, 2000

Genotype and phenotype of cytochrome P450 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndromeW M O'Neil, B M Gilfix, N Markoglou, et al.

International Journal of STD & AIDS|April 20, 2000

Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, S Khorasheh, et al.

AIDS Research and Human Retroviruses|July 20, 2001

Improvement of HIV-specific immunity in HIV-infected twins treated with highly active antiretroviral therapy, interleukin 2, and syngeneic adoptively transferred cellsC M Tsoukas, H M Turner, G E Hatzakis, et al.

Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:

Pageof 3

Clinical Pharmacology and Therapeutics|October 23, 1997

N-acetylation among HIV-positive patients and patients with AIDS: when is fast, fast and slow, slow?W M O'Neil, B M Gilfix, A DiGirolamo, et al.

British Journal of Clinical Pharmacology|December 14, 1999

Glucuronidation and sulphation of paracetamol in HIV-positive patients and patients with AIDSW M O'Neil, J C Pezzullo, A Di Girolamo, et al.

AIDS (London, England)|December 2, 1998

HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected personsN F Bernard, K Pederson, F Chung, et al.

Clinical Nephrology|January 25, 2006

Low urine pH is associated with reduced indinavir crystalluria in indinavir-treated HIV-infected individualsR F Gagnon, A I Alli, M D Edwardes, et al.

American Journal of Nephrology|January 9, 2001

The natural history of leukocyturia associated with indinavir treatment in HIV+ individualsR F Gagnon, S N Tecimer, A K Watters, et al.

Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006

Selection of molecular descriptors with artificial intelligence for the understanding of HIV-1 protease peptidomimetic inhibitors-activityS Sirois, C M Tsoukas, Kuo-Chen Chou, et al.

Archives of Surgery (Chicago, Ill. : 1960)|January 23, 1998

Effect of splenectomy on slowing human immunodeficiency virus disease progressionC M Tsoukas, N F Bernard, M Abrahamowicz, et al.

European Journal of Clinical Pharmacology|August 22, 2000

Genotype and phenotype of cytochrome P450 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndromeW M O'Neil, B M Gilfix, N Markoglou, et al.

International Journal of STD & AIDS|April 20, 2000

Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, S Khorasheh, et al.

AIDS Research and Human Retroviruses|July 20, 2001

Improvement of HIV-specific immunity in HIV-infected twins treated with highly active antiretroviral therapy, interleukin 2, and syngeneic adoptively transferred cellsC M Tsoukas, H M Turner, G E Hatzakis, et al.

Pageof 3